Celularity (CELU) Other Operating Expenses (2019 - 2025)
Celularity (CELU) posted quarterly Other Operating Expenses of $7.8 million for Q4 2025, up 2.99% year-over-year from $7.5 million in Q4 2024, and up 81.1% quarter-over-quarter from $4.3 million in Q3 2025.
Celularity (CELU) Other Operating Expenses (2019 - 2025) Analysis & Trends
Celularity (CELU) has reported Other Operating Expenses for 7 consecutive years, with $7.8 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Other Operating Expenses rose 2.99% year-over-year to $7.8 million; the TTM figure through Dec 2025 stood at $21.6 million (up 30.32% YoY), while the FY2025 annual figure was $21.6 million, up 30.32% from the prior year.
- Other Operating Expenses improved to $7.8 million in Q4 2025 per CELU's latest filing, from $4.3 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at $87.1 million in Q3 2023 and bottomed at -$45.7 million in Q3 2021.
- Historically, Other Operating Expenses has averaged $2.1 million across 5 years, with a median of $4.3 million in 2024.
- On a YoY basis, Other Operating Expenses climbed as much as 9186.17% in 2021 and fell as far as 930.33% in 2021.
- Celularity's Other Operating Expenses stood at -$18.1 million in 2021, then tumbled by 140.08% to -$43.4 million in 2022, then soared by 67.76% to -$14.0 million in 2023, then soared by 153.76% to $7.5 million in 2024, then rose by 2.99% to $7.8 million in 2025.
- Business Quant data shows CELU's Other Operating Expenses at $7.8 million in Q4 2025, $4.3 million in Q3 2025, and $5.6 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Celularity | 20.99 Mn | 14.82 Mn | -3.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.75 Mn |
| Sep 30, 2025 | 4.28 Mn |
| Jun 30, 2025 | 5.61 Mn |
| Mar 31, 2025 | 3.92 Mn |
| Dec 31, 2024 | 7.53 Mn |
| Sep 30, 2024 | 4.26 Mn |
| Jun 30, 2024 | 2.58 Mn |
| Mar 31, 2024 | 2.19 Mn |
| Dec 31, 2023 | -14.00 Mn |
| Sep 30, 2023 | 87.11 Mn |
| Jun 30, 2023 | 23.98 Mn |
| Mar 31, 2023 | 36.92 Mn |
| Dec 31, 2022 | -43.43 Mn |
| Sep 30, 2022 | -25.48 Mn |
| Jun 30, 2022 | -41.32 Mn |
| Mar 31, 2022 | 9.42 Mn |
| Dec 31, 2021 | -18.09 Mn |
| Sep 30, 2021 | -45.69 Mn |
| Jun 30, 2021 | 12.03 Mn |
| Mar 31, 2021 | 22.44 Mn |